Categories: News

Dr Noor Hisham: First COVID-19 vaccine clinical phase-3 report to be made available next week

The Health Ministry is anticipating at least one of the 12 companies currently developing the COVID-19 vaccine to release its first clinical report by next week, said Tan Sri Dr Noor Hisham Abdullah.

The Health Ministry’s director-general, who fell short of naming the company he was referring to, said the next step would be for the ministry to scrutinise the report before going over its efficacy.

Dr Noor Hisham said the ministry have yet to study any official clinical report concerning any COVID-19 vaccine, highlighting it as the first step needed towards approving the use of any antidote, despite Prime Minister Tan Sri Muhyiddin Yassin’s announcement of a deal sealed with Pfizer Inc to procure 12.8 million doses of the vaccine from the pharmaceutical company.

“We have found 12 vaccine companies who are currently in clinical phase-three of their testing, but we only managed to have negotiations with 10 of those companies.

“What we were told is that there is a big possibility that one of the companies might release their report or provide their clinical phase-three report sometime next week, so we are waiting to read it.

“They have to send their report dossiers to the National Pharmaceutical Regulatory Agency (NPRA) and the United States Food and Drug Administration (FDA) because as long as the vaccine is not licensed, we cannot sell it here,” he explained during his daily COVID-19 press conference.

Dr Noor Hisham also denied that being first in line for COVID-19 vaccines were equivalent to being test subjects or ‘lab rats’ for the new antidote, saying a great amount of research and evaluation is needed before approving the use of any vaccine.

“The research has to show a level of efficacy we can be satisfied with and also without any side effects, this is the most important, and these steps apply not only for the COVID-19 vaccine but other vaccines for other diseases as well,” he explained.

He was responding to claims by certain quarters of Malaysians being lab rats and testing subjects for Pfizer’s unreleased COVID-19 vaccine, a grouse triggered by Muhyiddin’s announcement of the deal. — Malay Mail

[ IMAGE SOURCE ]

Related reading

Recent Posts

Honda City 2026 facelift now open for booking in Malaysia: Early birds get RM3k rebate

Honda Malaysia has officially opened pre-orders for the Honda City 2026 facelift. Previously launched in…

1 hour ago

CelcomDigi offers 1,631GB 3-day National Day pass for RM6.90 until 30 September

If you're expecting to use a lot of mobile data over the Merdeka and Malaysia…

11 hours ago

Redmi Note 17 Series now open for pre-order in Malaysia. Here’s the full specs and features

Xiaomi Malaysia has officially opened pre-orders for the Redmi Note 17 Series in Malaysia, bringing…

17 hours ago

Maxis to fiberise 151 telco towers in Melaka under RM30 million project

Melaka is looking to improve mobile connectivity across the state by upgrading more of its…

20 hours ago

Charge+ Merdeka Promo: Get 30% extra EV charging credit with RM100 reload

Charge+ is having another EV charging promotion for Merdeka, and this time you can get…

21 hours ago

Gentari offers 15% off EV charging in Penang until 30 November

If you're driving your EV to Penang, Gentari is now offering a 15% discount on…

22 hours ago

This website uses cookies.